Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global NGS Informatics and Clinical Genomics Market by Type (LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions), By Application (Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global NGS Informatics and Clinical Genomics Market by Type (LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions), By Application (Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130051 3300 Medical Devices & Consumables 377 231 Pages 4.6 (31)
                                          

The global NGS informatics and clinical genomics market is expected to grow from USD 1.5 billion in 2018 to USD 2.8 billion by 2030, at a CAGR of 12.2% during the forecast period. The major factors driving the growth of this market are increasing adoption of NGS for research and development, growing demand for personalized medicine, and increasing number of clinical trials using NGS technology. The global NGS informatics and clinical genomics market is segmented on the basis of type into LIMS, data analysis tools, interpretation tools, storage solutions, computing solutions; on the basis of application into academic and research institutes (ARIs), biopharmaceutical industry (BPI), diagnostic industry (DIA), government agencies (GA), hospitals and clinics (H&C); on the basis of region into North America (NA), Latin America (LA), Europe(EU) Asia Pacific & Middle East & Africa(APMEA).

  1. The market for NGS Informatics and Clinical Genomics is expected to reach $3,814 million by 2022.
  2. Increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and obesity are driving the growth of the market for NGS Informatics and Clinical Genomics.
  3. Increasing adoption of personalized medicine in developed countries such as US, Japan, Germany etc, is also driving the growth of the market for NGS Informatics and Clinical Genomics.
  4. Increasing investments in research & development activities by key players in this industry are also driving the growth of this market.

Industry Growth Insights published a new data on “NGS Informatics and Clinical Genomics Market”. The research report is titled “NGS Informatics and Clinical Genomics Market research by Types (LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions), By Applications (Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics), By Players/Companies 2bPrecise, Epic Systems, Flatiron Health, GenomOncology, Illumina, IBM, Koninklijke Philips, QIAGEN, SOPHiA GENETICS”.

Scope Of The Report

Report Attributes

Report Details

Report Title

NGS Informatics and Clinical Genomics Market Research Report

By Type

LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions

By Application

Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics

By Companies

2bPrecise, Epic Systems, Flatiron Health, GenomOncology, Illumina, IBM, Koninklijke Philips, QIAGEN, SOPHiA GENETICS

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

231

Number of Tables & Figures

162

Customization Available

Yes, the report can be customized as per your need.


Global NGS Informatics and Clinical Genomics Industry Outlook


Global NGS Informatics and Clinical Genomics Market Report Segments:

The global NGS Informatics and Clinical Genomics market is segmented on the basis of:

Types

LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. 2bPrecise
  2. Epic Systems
  3. Flatiron Health
  4. GenomOncology
  5. Illumina
  6. IBM
  7. Koninklijke Philips
  8. QIAGEN
  9. SOPHiA GENETICS

Global NGS Informatics and Clinical Genomics Market Overview


Highlights of The NGS Informatics and Clinical Genomics Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. LIMS
    2. Data Analysis
    3. Interpretation Tools
    4. Storage
    5. Computing Solutions
  1. By Application:

    1. Academics and Research Institutes
    2. Biopharmaceutical Industry
    3. Diagnostic Industry
    4. Government Agencies
    5. Hospitals and Clinics
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the NGS Informatics and Clinical Genomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global NGS Informatics and Clinical Genomics Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. NGS Informatics and Clinical Genomics Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. NGS Informatics and Clinical Genomics Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. NGS Informatics and Clinical Genomics Market - Supply Chain
   4.5. Global NGS Informatics and Clinical Genomics Market Forecast
      4.5.1. NGS Informatics and Clinical Genomics Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. NGS Informatics and Clinical Genomics Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. NGS Informatics and Clinical Genomics Market Absolute $ Opportunity

5. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
      5.3.1. LIMS
      5.3.2. Data Analysis
      5.3.3. Interpretation Tools
      5.3.4. Storage
      5.3.5. Computing Solutions
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
      6.3.1. Academics and Research Institutes
      6.3.2. Biopharmaceutical Industry
      6.3.3. Diagnostic Industry
      6.3.4. Government Agencies
      6.3.5. Hospitals and Clinics
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global NGS Informatics and Clinical Genomics Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global NGS Informatics and Clinical Genomics Demand Share Forecast, 2019-2029

9. North America NGS Informatics and Clinical Genomics Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
      9.4.1. Academics and Research Institutes
      9.4.2. Biopharmaceutical Industry
      9.4.3. Diagnostic Industry
      9.4.4. Government Agencies
      9.4.5. Hospitals and Clinics
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
      9.7.1. LIMS
      9.7.2. Data Analysis
      9.7.3. Interpretation Tools
      9.7.4. Storage
      9.7.5. Computing Solutions
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America NGS Informatics and Clinical Genomics Demand Share Forecast, 2019-2029

10. Latin America NGS Informatics and Clinical Genomics Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
      10.4.1. Academics and Research Institutes
      10.4.2. Biopharmaceutical Industry
      10.4.3. Diagnostic Industry
      10.4.4. Government Agencies
      10.4.5. Hospitals and Clinics
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
      10.7.1. LIMS
      10.7.2. Data Analysis
      10.7.3. Interpretation Tools
      10.7.4. Storage
      10.7.5. Computing Solutions
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America NGS Informatics and Clinical Genomics Demand Share Forecast, 2019-2029

11. Europe NGS Informatics and Clinical Genomics Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
      11.4.1. Academics and Research Institutes
      11.4.2. Biopharmaceutical Industry
      11.4.3. Diagnostic Industry
      11.4.4. Government Agencies
      11.4.5. Hospitals and Clinics
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
      11.7.1. LIMS
      11.7.2. Data Analysis
      11.7.3. Interpretation Tools
      11.7.4. Storage
      11.7.5. Computing Solutions
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe NGS Informatics and Clinical Genomics Demand Share, 2019-2029

12. Asia Pacific NGS Informatics and Clinical Genomics Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
      12.4.1. Academics and Research Institutes
      12.4.2. Biopharmaceutical Industry
      12.4.3. Diagnostic Industry
      12.4.4. Government Agencies
      12.4.5. Hospitals and Clinics
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
      12.7.1. LIMS
      12.7.2. Data Analysis
      12.7.3. Interpretation Tools
      12.7.4. Storage
      12.7.5. Computing Solutions
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific NGS Informatics and Clinical Genomics Demand Share, 2019-2029

13. Middle East & Africa NGS Informatics and Clinical Genomics Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Application
      13.4.1. Academics and Research Institutes
      13.4.2. Biopharmaceutical Industry
      13.4.3. Diagnostic Industry
      13.4.4. Government Agencies
      13.4.5. Hospitals and Clinics
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa NGS Informatics and Clinical Genomics Market Size and Volume Forecast by Type
      13.7.1. LIMS
      13.7.2. Data Analysis
      13.7.3. Interpretation Tools
      13.7.4. Storage
      13.7.5. Computing Solutions
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa NGS Informatics and Clinical Genomics Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global NGS Informatics and Clinical Genomics Market: Market Share Analysis
   14.2. NGS Informatics and Clinical Genomics Distributors and Customers
   14.3. NGS Informatics and Clinical Genomics Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. 2bPrecise
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Epic Systems
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Flatiron Health
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. GenomOncology
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Illumina
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. IBM
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Koninklijke Philips
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. QIAGEN
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. SOPHiA GENETICS
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. F

Our Trusted Clients

Contact Us